In silico evaluation of gadofosveset pharmacokinetics in different population groups using the Simcyp® simulator platform

被引：6
|
作者：
Marios Spanakis
Kostas Marias
机构：
[1] Foundation of Research & Technology-Hellas (FORTH),Computational Medicine Laboratory, Institute of Computer Science
来源：
In Silico Pharmacology | / 2卷 / 1期
关键词：
Gadofosveset; Gadolinium-based contrast agents; PBPK; Simcyp; DCE-MRI; Medical imaging; Pharmacokinetics;
D O I：
10.1186/s40203-014-0002-x
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Population PBPK modeling using parametric and nonparametric methods of the Simcyp Simulator, and Bayesian samplers
    Wedagedera, Janak R.
    Afuape, Anthonia
    Chirumamilla, Siri Kalyan
    Momiji, Hiroshi
    Leary, Robert
    Dunlavey, Mike
    Matthews, Richard
    Abduljalil, Khaled
    Jamei, Masoud
    Bois, Frederic Y.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022, 11 (06): : 755 - 765
  • [2] Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation
    Ghoneim, Ragia H.
    Thabit, Abrar K.
    Lashkar, Manar O.
    Ali, Ahmed S.
    ITALIAN JOURNAL OF PEDIATRICS, 2021, 47 (01)
  • [3] Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation
    Ragia H. Ghoneim
    Abrar K. Thabit
    Manar O. Lashkar
    Ahmed S. Ali
    Italian Journal of Pediatrics, 47
  • [4] AN IN SILICO SIMULATION STUDY OF EXTENDED INTERVAL DOSING OF ATEZOLIZUMAB USING POPULATION PHARMACOKINETICS
    Peer, C.
    Schmidt, K.
    Arisa, O.
    Richardson, W.
    Paydary, K.
    Goldstein, D.
    Figg, W.
    Ratain, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S25 - S26
  • [5] Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currently recommended doses
    Zvada, Simbarashe P.
    Denti, Paolo
    Donald, Peter R.
    Schaaf, H. Simon
    Thee, Stephanie
    Seddon, James A.
    Seifart, Heiner I.
    Smith, Peter J.
    McIlleron, Helen M.
    Simonsson, Ulrika S. H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (05) : 1339 - 1349
  • [6] Evaluation of Individualized Cefepime Dosing Strategy Using Population Pharmacokinetics
    Mo, Yoonsun
    Shcherbakova, Natalia
    Inman, Kelsey L.
    Li, Wai Kin
    Kovalenko, Kateryna
    Rosenberg, Joshua
    Orsini, Jose
    Truong, James
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (03): : 359 - 365
  • [7] Evaluation of interethnic differences in repinotan pharmacokinetics by using population approach
    Tanigawa, Takahiko
    Heinig, Roland
    Kuroki, Yoshihiro
    Higuchi, Shun
    DRUG METABOLISM AND PHARMACOKINETICS, 2006, 21 (01) : 61 - 69
  • [8] Population pharmacokinetics of arbekacin in different infectious disease settings and evaluation of dosing regimens
    Hagihara, Mao
    Kato, Hideo
    Hamada, Yukihiro
    Hirai, Jun
    Sakanashi, Daisuke
    Suematsu, Hiroyuki
    Nishiyama, Naoya
    Koizumi, Yusuke
    Yamagishi, Yuka
    Matsuura, Katsuhiko
    Mikamo, Hiroshige
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2016, 22 (7-8) : 436 - 443
  • [9] AN EVALUATION OF POINT AND INTERVAL ESTIMATES IN POPULATION PHARMACOKINETICS USING NONMEM ANALYSIS
    WHITE, DB
    WALAWANDER, CA
    TUNG, Y
    GRASELA, TH
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1991, 19 (01): : 87 - 112
  • [10] EVALUATION OF THEOPHYLLINE PHARMACOKINETICS IN A PEDIATRIC POPULATION USING MIXED EFFECTS MODELS
    DRISCOLL, MS
    LUDDEN, TM
    CASTO, DT
    LITTLEFIELD, LC
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1989, 17 (02): : 141 - 168
12345